These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22465638)

  • 1. The future of combining inhaled drugs for COPD.
    Bjerg A; Lundbäck B; Lötvall J
    Curr Opin Pharmacol; 2012 Jun; 12(3):252-5. PubMed ID: 22465638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?
    Salama RO; Young PM; Rogueda P; Lallement A; Iliev I; Traini D
    Expert Opin Pharmacother; 2011 Aug; 12(12):1913-32. PubMed ID: 21714776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medical treatment of COPD].
    Vestbo J; Titlestad IL
    Ugeskr Laeger; 2013 Apr; 175(18):1261-4. PubMed ID: 23651802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhaled corticosteroid/beta-2 agonist therapy in moderate COPD].
    Yıldırım N
    Tuberk Toraks; 2010; 58(2):192-201. PubMed ID: 20865575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Triple therapy in chronic obstructive pulmonary disease].
    Baloira A
    Arch Bronconeumol; 2010; 46 Suppl 8():25-30. PubMed ID: 21334553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging trends in the therapy of COPD: bronchodilators as mono- and combination therapies.
    Fitzgerald MF; Fox JC
    Drug Discov Today; 2007 Jun; 12(11-12):472-8. PubMed ID: 17532532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment.
    Pelaia G; Muzzio CC; Vatrella A; Maselli R; Magnoni MS; Rizzi A
    Expert Opin Pharmacother; 2015; 16(13):2009-21. PubMed ID: 26194120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease?
    López-Campos JL; Calero Acuña C
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):43-51. PubMed ID: 23551023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple therapy for the management of COPD: a review.
    Gaebel K; McIvor RA; Xie F; Blackhouse G; Robertson D; Assasi N; Hernandez P; Goeree R
    COPD; 2011 Jun; 8(3):206-43. PubMed ID: 21513437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New drug therapy of chronic obstructive pulmonary disease].
    Kino H
    Nihon Rinsho; 2003 Dec; 61(12):2175-80. PubMed ID: 14674329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can β2-adrenoceptor agonists, anticholinergic drugs, and theophylline contribute to the control of pulmonary inflammation and emphysema in COPD?
    Zhang WH; Zhang Y; Cui YY; Rong WF; Cambier C; Devillier P; Bureau F; Advenier C; Gustin P
    Fundam Clin Pharmacol; 2012 Feb; 26(1):118-34. PubMed ID: 22044554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple inhalers for obstructive airways disease: will they be useful?
    Barnes PJ
    Expert Rev Respir Med; 2011 Jun; 5(3):297-300. PubMed ID: 21702649
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug therapy of airway obstruction. "Completely different for asthma and COPD"].
    MMW Fortschr Med; 2008 May; 150(20):14, 16. PubMed ID: 18605635
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bronchodilators in chronic obstructive pulmonary disease (COPD)].
    Gillissen A; Buhl R; Rabe KF; Vogelmeier C; Welte T
    Med Klin (Munich); 2005 May; 100(5):246-54. PubMed ID: 15902378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current strategy of bronchodilator therapy for chronic obstructive pulmonary disease (COPD)].
    Teramoto S
    Nihon Rinsho; 1999 Sep; 57(9):2051-5. PubMed ID: 10497405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of distal airways involvement in COPD].
    Devillier P; Jebrak G; Morel H; Chinet T; Didier A; Roche N
    Rev Mal Respir; 2011 Dec; 28(10):1340-56. PubMed ID: 22152941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
    Onoue S; Misaka S; Kawabata Y; Yamada S
    Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging therapeutic strategies in COPD.
    Babu KS; Morjaria JB
    Drug Discov Today; 2015 Mar; 20(3):371-9. PubMed ID: 25462534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.